Qura, the creator of QSmart implantable technology that monitors IOP in glaucoma patients, has received Series A funding from InFocus Capital Partners to advance the technology toward commercialization.
"Qura has developed and licensed patented proprietary technology for wireless, 'active,' internally placed sensors, which measure pressure in approximately 20 places inside the human anatomy. To date, the patent portfolio contains approximately 60 patent or patent pending applications," Doug P. Adams, Qura co-founder, president and CEO, told Healio.com/OSN.
QSmart, a micro-sized wireless
Uncategorized